EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Impact of the use of Extended™ Wear Infusion sets on metabolic, ultrasound, and psychological outcomes in adults with type 1 diabetes using the Medtronic MiniMed 780G: a pilot randomized controlled trial

Kamila Susuł iD, Damian Ucieklak iD, Katarzyna Cyranka iD, Maciej Małecki iD, Tomasz Klupa iD, Bartlomiej Matejko iD

Endokrynologia Polska · 2026

DOI: 10.5603/ep.112819 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Endokrynologia Polska, 2026. Verfasst von Kamila Susuł und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolic Diseases and Diabetology, University Hospital, Krakow, Poland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin Infusion Systems, Insulin, Hypoglycemic Agents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: In people with type 1 diabetes (PwT1DM), insulin infusion sets (IIS) are often regarded as the most fragile componentof insulin pump therapy. Standard IISs should be replaced every 2-3 days to prevent site complications and hyperglycemia. The objectiveof this randomized controlled trial was to evaluate the impact of 7-day Extended™ Wear Infusion sets (EIS; Medtronic MiniMed,Northridge, CA, USA) on metabolic, ultrasound (USG), and psychological outcomes in PwT1DM treated with the MiniMed 780G system(MM780G, Medtronic MiniMed, Northridge, CA, USA). MATERIAL AND METHODS: Fifteen participants in both the intervention (EIS) and control groups (standard IIS) completed the 3-month study.One participant in the control group did not attend the follow-up USG examination; however, all other clinical, continuous glucose monitoring(CGM), and questionnaire data were available and included in the analyses. In the intervention group, the mean age was 36.1 ± 10.7years, diabetes duration 20.3 ± 7.6 years, body mass index (BMI) 24.9 ± 4.0 kg/m², and glycated hemoglobin A1c (HbA1c) 6.7 ± 0.5%. There were no significant baseline differences between groups in age, diabetes duration, CGM indices, or HbA1c. RESULTS: Across the study period, no statistically significant differences were observed between the control and intervention groups with respect to the number of lipohypertrophic lesions, the volume of the largest lesion, HbA1c, CGM indices or insulin requirements. Inboth groups (with no between-group differences), World Health Organization (WHO) 5 scores indicated improvements in psychologicalwell-being. Notably, 80% of participants reported that EIS were more comfortable than standard sets, and 73.3% stated that the newinfusion sets met their expectations. Two-thirds of participants found that the new infusion sets made life easier. CONCLUSIONS: These findings suggest that EIS are a safe and effective option for glycemic management in adults, without increasing lipohypertrophic lesions and with high patient acceptance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Insulin Infusion SystemsInsulinHypoglycemic AgentsHumansFemalePilot ProjectsAdultMaleContinuous Glucose MonitoringMiddle AgedBlood GlucoseGlycated HemoglobinUltrasonography

Stichwörter der Autor:innen

7-day infusion setCSIIcontinuous subcutaneous insulin infusiondiabetes technologyextended-wear infusion setglycemic controinfusion set wear timeinsulin deliveryinsulin pump therapytype 1 diabetes

Substanzen

InsulinHypoglycemic AgentsBlood GlucoseGlycated Hemoglobin

Autor:innen und Institutionen

  • Department of Metabolic Diseases and Diabetology, University Hospital, Krakow, Poland.
  • Department of Metabolic Diseases, Centre for Advanced Technologies in Diabetes, Jagiellonian University Medical College, Krakow, Poland.
  • Psychodiabetology Unit, Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland.

ORCID-Profile: Kamila Susuł, Damian Ucieklak, Katarzyna Cyranka, Maciej Małecki, Tomasz Klupa, Bartlomiej Matejko

Zitieren

APA

Susuł, K., Ucieklak, D., Cyranka, K., Małecki, M., Klupa, T., & Matejko, B. (2026). Impact of the use of Extended™ Wear Infusion sets on metabolic, ultrasound, and psychological outcomes in adults with type 1 diabetes using the Medtronic MiniMed 780G: a pilot randomized controlled trial. Endokrynologia Polska. https://doi.org/10.5603/ep.112819

Vancouver

Susuł K, Ucieklak D, Cyranka K, Małecki M, Klupa T, Matejko B. Impact of the use of Extended™ Wear Infusion sets on metabolic, ultrasound, and psychological outcomes in adults with type 1 diabetes using the Medtronic MiniMed 780G: a pilot randomized controlled trial. Endokrynologia Polska. 2026. doi:10.5603/ep.112819

BibTeX
@article{Susu2026,
  author = {Susuł, Kamila and Ucieklak, Damian and Cyranka, Katarzyna and Małecki, Maciej and Klupa, Tomasz and Matejko, Bartlomiej},
  title = {Impact of the use of Extended™ Wear Infusion sets on metabolic, ultrasound, and psychological outcomes in adults with type 1 diabetes using the Medtronic MiniMed 780G: a pilot randomized controlled trial},
  journal = {Endokrynologia Polska},
  year = {2026},
  doi = {10.5603/ep.112819}
}
Kostenlos starten →